PubMed Central
Cure8 research brief
Why This Matters
This study identifies a new mechanism by which a probiotic strain and its metabolite regulate enteric neurons to reduce colitis in mice, which could point to novel therapeutic targets for IBD in the future.
Who Should Pay Attention
Researchers (microbiome, neuroimmune, IBD), translational scientists, and clinicians following microbiome-based therapies.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthMetadata only
What To Know
This lab and mouse study reports that a strain of Lactobacillus plantarum (A736) and its metabolite indole-3-lactic acid (ILA) reduced inflammation in a DSS mouse colitis model.
The authors link the protective effect to increased choline acetyltransferase–expressing (ChAT+) enteric neurons and higher acetylcholine, and show that removing colonic ChAT+ neurons abolishes the benefit — suggesting a microbiota→metabolite→enteric-neuron→immune pathway.
The work combines patient association data (lower Lactobacillus with worse ulcerative colitis), multi-omics, bacterial metabolite identification, and mechanistic mouse experiments. The findings point to a novel ILA–ChAT+ neuron axis that influences gut immunity and could be explored for therapeutic approaches, but the study is preclinical.
Keep In Mind
Preclinical (mouse and lab) evidence with supportive human microbiome association data; not an approved treatment and requires clinical testing.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationPubMed Central
JournalAdv Sci (Weinh)
AuthorsXia, Bing, Sun, Yuwei, Wang, Jialin +13 more
Indexed viaPubMed Central
Source typeResearch repository record
PublishedOct 14, 2026, 12:00 AM
Content availableMetadata only
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Enteric ChAT-Expressing Neurons Mediate the Protective Effect of Lactobacillus plantarum in Inflammatory Bowel Disease.
The paper suggests a specific gut bacterium and its metabolite can protect against intestinal inflammation in mice by acting on enteric neurons, revealing a new neuro-immune pathway that could inform future IBD...
Extracellular Vesicles Derived from Elaeocarpus braceanus Alleviate DSS-Induced Ulcerative Colitis in Mice Through Multiple Pathways
This study describes a new plant-derived nanoparticle (EBDEVs) that reduced inflammation and improved colon health in a mouse model of ulcerative colitis and altered the gut microbiota — early evidence that may guide...
Chitosan–Unconjugated Bilirubin Microspheres Alleviate Dysbiosis, Immune Dysregulation, and Intestinal Barrier Damage in Ulcerative Colitis
This study reports a new colon-targeted delivery system for unconjugated bilirubin that reduced inflammation and improved mucosal healing in a mouse model of ulcerative colitis; it could inform future drug-development...